News
By Lori Solomon HealthDay ReporterFRIDAY, June 20, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Investor's Business Daily on MSN1d
How KalVista Pharma Is Taking On A Rare But Deadly DiseaseBiotech stock KalVista has soared recently, as the firm looks to fundamentally change the treatment landscape for HAE ...
MyChesCo on MSN3d
FDA Approves ANDEMBRY® for Preventing Hereditary Angioedema AttacksThe U.S. Food and Drug Administration (FDA) has approved ANDEMBRY® (garadacimab-gxii), developed by CSL, as the first ...
The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback